• Explore /
  • Poster
  • / Enzalutamide plus exemestane: A pilot study to assess safety, pharmacokinetics, and effects on circulating estrogens in women with advanced hormone-positive breast cancer.

Enzalutamide plus exemestane: A pilot study to assess safety, pharmacokinetics, and effects on circulating estrogens in women with advanced hormone-positive breast cancer.

Abstract Poster

Authors

Lee Schwartzberg

Lee Steven Schwartzberg

The University of Tennessee Health Science Center, Memphis, TN

Lee Steven Schwartzberg , Denise A. Yardley , Anthony D. Elias , Manish R. Patel , Ayca Gucalp , Howard A. Burris III, Amy C. Peterson , Alison L. Hannah , Martha Elizabeth Blaney , Jackie Gibbons , Iulia Cristina Tudor , Joyce L. Steinberg , Patricia LoRusso , Jeffrey R. Infante , Clifford A. Hudis , Tiffany A. Traina

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Clinical Trial Registration Number

NCT01597193

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 545)

DOI

10.1200/jco.2014.32.15_suppl.545

Abstract #

545

Poster Bd #

9

Abstract Disclosures

Similar Posters

First Author: Olivier Rixe

First Author: Arpit Rao

First Author: Denise A. Yardley

Poster

2013 Genitourinary Cancers Symposium

Enzalutamide in combination with docetaxel in men with prostate cancer (PC): Preliminary results from a phase I study.

Enzalutamide in combination with docetaxel in men with prostate cancer (PC): Preliminary results from a phase I study.

First Author: Mark T. Fleming